The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Paul E. Goss

Massachusetts General Hospital Cancer Center and Harvard Medical School

Boston

MA 02114

USA

[email]@interlog.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA 02114, USA. 2006
  • Division of Hematology/Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada. 2001 - 2004
  • Princess Margaret Hospital, University Health Network, 610 University Avenue, Room 5-303, Canada. 2001 - 2004
  • Breast Cancer Prevention Program, University of Toronto, Princess Margaret Hospital, University Health Network. 2003 - 2004
  • Princess Margaret Hospital, Toronto, Canada. 2000 - 2001
  • The Toronto Hospital-General Division, Canada. 1998 - 2000

References

  1. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial. Goss, P.E. Semin. Oncol. (2006) [Pubmed]
  2. Aromatase inhibitors for chemoprevention. Goss, P.E., Strasser-Weippl, K. Best Pract. Res. Clin. Endocrinol. Metab. (2004) [Pubmed]
  3. Prevention strategies with aromatase inhibitors. Goss, P.E., Strasser-Weippl, K. Clin. Cancer Res. (2004) [Pubmed]
  4. The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats. Goss, P.E., Qi, S., Josse, R.G., Pritzker, K.P., Mendes, M., Hu, H., Waldman, S.D., Grynpas, M.D. Bone (2004) [Pubmed]
  5. Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats. Goss, P.E., Qi, S., Cheung, A.M., Hu, H., Mendes, M., Pritzker, K.P. Clin. Cancer Res. (2004) [Pubmed]
  6. The selective estrogen receptor modulator SCH 57068 prevents bone loss, reduces serum cholesterol and blocks estrogen-induced uterine hypertrophy in ovariectomized rats. Goss, P.E., Qi, S., Cheung, A.M., Hu, H., Mendes, M., Pritzker, K.P. J. Steroid Biochem. Mol. Biol. (2004) [Pubmed]
  7. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. Goss, P.E., Ingle, J.N., Martino, S., Robert, N.J., Muss, H.B., Piccart, M.J., Castiglione, M., Tu, D., Shepherd, L.E., Pritchard, K.I., Livingston, R.B., Davidson, N.E., Norton, L., Perez, E.A., Abrams, J.S., Therasse, P., Palmer, M.J., Pater, J.L. N. Engl. J. Med. (2003) [Pubmed]
  8. Breast cancer prevention--clinical trials strategies involving aromatase inhibitors. Goss, P.E. J. Steroid Biochem. Mol. Biol. (2003) [Pubmed]
  9. Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors. Goss, P.E., Strasser, K. Drugs (2002) [Pubmed]
  10. Anti-aromatase agents in the treatment and prevention of breast cancer. Goss, P. Cancer. Control (2002) [Pubmed]
  11. Letrozole for the management of breast cancer. Goss, P.E., Smith, R.E. Expert. Rev. Anticancer. Ther (2002) [Pubmed]
  12. Aromatase inhibitors in the treatment and prevention of breast cancer. Goss, P.E., Strasser, K. J. Clin. Oncol. (2001) [Pubmed]
  13. Chemoprevention with aromatase inhibitors--trial strategies. Goss, P.E., Strasser, K. J. Steroid Biochem. Mol. Biol. (2001) [Pubmed]
  14. Preliminary data from ongoing adjuvant aromatase inhibitor trials. Goss, P.E. Clin. Cancer Res. (2001) [Pubmed]
  15. Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer. Goss, P.E., Oza, A., Goel, R., Nabholtz, J.M., De Coster, R., Bruynseels, J., Reid, C., Wadden, N., Crump, M., Tye, L.M. Breast Cancer Res. Treat. (2000) [Pubmed]
  16. Liarozole fumarate (R85246): in the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer. Goss, P.E., Strasser, K., Marques, R., Clemons, M., Oza, A., Goel, R., Blackstein, M., Kaizer, L., Sterns, E.E., Nabholtz, J.M., De Coster, R., Crump, M., Abdolell, M., Qi, S. Breast Cancer Res. Treat. (2000) [Pubmed]
  17. Current perspectives on radiation-induced breast cancer. Goss, P.E., Sierra, S. J. Clin. Oncol. (1998) [Pubmed]
 
WikiGenes - Universities